Open AccessEffect of Atorvastatin on the Disease Activity and Severity of Rheumatoid Arthritis: Double-Blind Randomized Controlled Trial
Author(s) -
Karim Mowla,
Elham Rajai,
Ali Ghorbani,
Mehrdad Dargahi-Malamir,
Mohammad Bahadoram,
Shooka Mohammadi
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/16538.7814
Subject(s) - atorvastatin , medicine , rheumatoid arthritis , erythrocyte sedimentation rate , placebo , randomized controlled trial , arthritis , gastroenterology , physical therapy , pathology , alternative medicine
HMG-CoA (3-hydroxy-3- methylglutary lcoenzyme A) reductase inhibitors (statins) have anti-inflammatory properties which may be particularly useful in rheumatoid arthritis to suppress disease activity and inflammatory factors.